Case number 1:20-cv-01009
AbbVie Inc. et al v. Alembic Pharmaceuticals Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Sep 19, 2022 | 46 | STIPULATION AND ORDER to Extend Time, re (135 in 1:20-cv-00968-MSG) STIPULATION TO EXTEND TIME Scheduling Order (D.I 81) to as Modified filed by AbbVie Inc., (45 in 1:20-cv-01009-MSG) STIPULATION TO EXTEND TIME Scheduling Order (D.I. 81) to be modified filed by AbbVie Inc. Signed by Judge Mitchell S. Goldberg on 09/19/2022. Associated Cases: 1:20-cv-00968-MSG, 1:20-cv-01009-MSG(smg) (Entered: 09/19/2022) (5) |
| Sep 9, 2022 | 45 | STIPULATION TO EXTEND TIME Scheduling Order (D.I. 81) to be modified - filed by AbbVie Inc.. (Streifthau-Livizos, Michelle) (Entered: 09/09/2022) (5) |
| Aug 29, 2022 | 44 | STIPULATION AND ORDER. Signed by Judge Mitchell S. Goldberg on 8/29/2022. (apk) (Entered: 08/29/2022) (3) |
| Jul 5, 2022 | 43 | Order (1) Docket Text: ORDER: The Markman hearing scheduled for July 12, 2022 at 9:00 am is CANCELLED. Signed by Judge Mitchell S. Goldberg on 07/05/2022. Associated Cases: 1:20-cv-00968-MSG, 1:20-cv-01009-MSG(smg) |
| Jul 5, 2022 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Mitchell S. Goldberg - Telephone Conference held on 7/5/2022. Associated Cases: 1:20-cv-00968-MSG, 1:20-cv-01009-MSG(smg) |
| Mar 8, 2022 | 42 | Stipulation and Order (2) Docket Text: STIPULATION AND ORDER. Signed by Judge Mitchell S. Goldberg on 3/8/2022. Associated Cases: 1:20-cv-00968-MSG, 1:20-cv-01009-MSG(nmg) |
| Mar 7, 2022 | 41 | Stipulation to EXTEND Time (2) Docket Text: Joint STIPULATION TO EXTEND TIME to submit a Joint Claim Construction Statement to March 8, 2022 - filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd.. (Ormerod, Eve) |
| Mar 2, 2022 | 40 | Stipulation and Order (2) Docket Text: STIPULATION AND ORDER to extend time to submit a Joint Claim Construction Statement to March 4, 2022. Signed by Judge Mitchell S. Goldberg on 3/2/2022. Associated Cases: 1:20-cv-00968-MSG, 1:20-cv-01009-MSG(nmg) |
| Mar 2, 2022 | 39 | Stipulation to EXTEND Time (2) Docket Text: Joint STIPULATION TO EXTEND TIME to submit a Joint Claim Construction Statement to March 4, 2022 - filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd.. (Ormerod, Eve) |
| Mar 1, 2022 | 38 | Stipulation and Order (3) Docket Text: STIPULATION AND ORDER to Extend Time. Signed by Judge Mitchell S. Goldberg on 3/1/2022. Associated Cases: 1:20-cv-00968-MSG, 1:20-cv-01009-MSG(nmg) |
| Jan 18, 2022 | 37 | Stipulation and Order (3) Docket Text: STIPULATION AND ORDER TO EXTEND TIME (See Order for further details). Signed by Judge Mitchell S. Goldberg on 1/18/2022. Associated Cases: 1:20-cv-00968-MSG, 1:20-cv-01009-MSG(myr) |
| Jan 13, 2022 | 36 | Stipulation to EXTEND Time (3) Docket Text: Joint STIPULATION TO EXTEND TIME (see stipulation for various deadlines) to Various Dates - filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd.. (Ormerod, Eve) |
| Sep 23, 2021 | 35 | Stipulation and Order (2) Docket Text: STIPULATION AND ORDER TO EXTEND TIME, the deadline for the parties to exchange a list of those claim term(s)/phrase(s) for construction and their proposed claim constructions of such term(s)/phrase(s) shall be extended from September 23, 2021 to September 27, 2021 (See Order for further details). Signed by Judge Mitchell S. Goldberg on 9/23/21. (mal) |
| Sep 23, 2021 | 34 | Stipulation to EXTEND Time (2) Docket Text: Joint STIPULATION TO EXTEND TIME to Exchange a List of Claim Term(s)/Phrase(s) for Construction and Proposed Claim Constructions to September 27, 2021 - filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd.. (Ormerod, Eve) |
| Sep 21, 2021 | 33 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME of Substantial Completion of Document Production to November 29, 2021 - filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd.. (Belgam, Neal) |
| Jul 9, 2021 | 32 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Serve Defendants' Initial Invalidity Contentions to July 21, 2021 - filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd.. (Ormerod, Eve) |
| Jul 6, 2021 | 31 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Serve Defendants' Initial Invalidity Contentions to July 14, 2021 - filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd.. (Ormerod, Eve) |
| Apr 15, 2021 | 30 | Scheduling Order (14) Docket Text: ORDER, C.A. No. 20-1009-MSG shall be consolidated with C.A. No. 20-00968-MSG (the Consolidated Action) for all purposes, and all papers shall be filed in the Consolidated Action. SCHEDULING ORDER: Joinder of Parties due by 10/15/2021. Amended Pleadings due by 10/15/2021. Fact Discovery completed by 5/5/2022. Opening Expert Reports due by 7/22/2022. Rebuttal Expert Reports due by 9/23/2022. Status Report due by 5/12/2022. Claim Construction Opening Brief due by 11/10/2021. Claim Construction Answering Brief due by 12/9/2021. Claim Construction Reply Brief due by 1/11/2022. A Markman Hearing is set for 2/24/2022 at 09:00 AM before Judge Mitchell S. Goldberg. **(See Order for further details.) Signed by Judge Mitchell S. Goldberg on 4/15/2021. Associated Cases: 1:20-cv-00968-MSG, 1:20-cv-01009-MSG(nmg) |
| Apr 15, 2021 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: 20-cv-00968-MSG. All future filings should be made in Lead Case No. 20-cv-00968-MSG. only. (nmg) |
| Mar 16, 2021 | 29 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Interrogatories and First Set of Requests for Production to Defendant filed by AbbVie Inc., Genentech, Inc..(Taylor, James) |
| Mar 16, 2021 | 28 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Disclosures, Paragraph 3 Disclosures and Identification of Asserted Patents filed by AbbVie Inc., Genentech, Inc..(Taylor, James) |
| Mar 15, 2021 | 27 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of 1) Defendants Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc., and Alembic Global Holding SA's Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery and 2) Defendants Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc., and Alembic Global Holding SA's Rule 26(a)(1) Initial Disclosures filed by Alembic Global Holding SA, Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc..(Wilson, Samantha) |
| Mar 11, 2021 | 26 | Order on Motion to Appear Pro Hac Vice (2) Docket Text: ORDER granting [25] Motion to Appear Pro Hac Vice of Attorney Christopher R. Hall in cases 1:20-cv-00968-MSG, 1:20-cv-01009-MSG. Signed by Judge Mitchell S. Goldberg on 3/11/2021. Associated Cases: 1:20-cv-00968-MSG, 1:20-cv-01009-MSG. (kmd) |
| Mar 11, 2021 | 25 | Certification of Counsel (1) |
| Mar 11, 2021 | 25 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Christopher R. Hall - filed by AbbVie Inc., Genentech, Inc.. (Attachments: # (1) Certification of Counsel)(Taylor, James) |
| Mar 11, 2021 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Mitchell S. Goldberg - Telephone Conference held on 3/11/2021 (25 minutes). (myr) |
| Mar 9, 2021 | 24 | Proposed Order (16) Docket Text: PROPOSED ORDER Joint Proposed Scheduling Order by AbbVie Inc., Genentech, Inc.. (Taylor, James) |
| Mar 8, 2021 | 23 | Stipulation and Order (2) Docket Text: JOINT STIPULATION AND ORDER Extending Date for Filing Joint Report of the Rule 26(f) Meeting. Signed by Judge Mitchell S. Goldberg on 3/8/2021. (kmd) |
| Mar 5, 2021 | 22 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME filed joint discovery plan to March 9, 2021 - filed by AbbVie Inc., Genentech, Inc.. (Taylor, James) |
| Feb 26, 2021 | 21 | Order on Motion to Appear Pro Hac Vice (3) Docket Text: ORDER granting [20] Motion to Appear Pro Hac Vice of Attorney Paige Cloud. Signed by Judge Mitchell S. Goldberg on 2/26/2021. (kmd) |
| Feb 26, 2021 | 20 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Paige Cloud - filed by Alembic Global Holding SA, Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc.. (Wilson, Samantha) |
| Feb 17, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Dennies Varughese, Pharm.D for Alembic Global Holding SA, Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Feb 16, 2021 | 19 | Stipulation and Order (2) Docket Text: Joint STIPULATION AND ORDER. Signed by Judge Mitchell S. Goldberg on 2/16/2021. (nmg) |
| Feb 16, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Robert Stout for Alembic Global Holding SA, Alembic Pharmaceuticals Ltd. and Alembic Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) |
| Feb 11, 2021 | 18 | Stipulation (2) |
| Feb 11, 2021 | 18 | Main Document (2) Docket Text: Letter to Judge Mitchell S. Goldberg from James D. Taylor, Jr. regarding Scheduling Conference and Deadlines for Initial Disclosures. (Attachments: # (1) Stipulation)(Taylor, James) |
| Jan 28, 2021 | 17 | Order Setting Teleconference (1) Docket Text: ORDER, an Initial Pretrial Conference is set for 3/11/2021 at 10:00 AM before Judge Mitchell S. Goldberg. The conference will be conducted via telephone and held on the record. Counsel are directed to dial in to 571-353-2300, passcode 427102124#. Signed by Judge Mitchell S. Goldberg on 1/28/2021. (nmg) |
| Jan 22, 2021 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge Mitchell S. Goldberg of the United States District Court for the Eastern District of Pennsylvania. Please include the initials of the Judge (MSG) after the case number on all documents filed. Associated Cases: 1:20-cv-00968-MSG, 1:20-cv-01009-MSG (rjb) |
| Dec 3, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Scott F. Peachman for AbbVie Inc. and Genentech, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-00968-LPS, 1:20-cv-01009-LPS(mal) |
| Nov 12, 2020 | 16 | Certification of Counsel (1) |
| Nov 12, 2020 | 16 | Main Document (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Scott F. Peachman - filed by AbbVie Inc., Genentech, Inc.. (Attachments: # (1) Certification of Counsel)(Taylor, James) |
| Nov 12, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [16] MOTION for Pro Hac Vice Appearance of Attorney Scott F. Peachman filed by Genentech, Inc., AbbVie Inc. Signed by Judge Leonard P. Stark on 11/12/20. (ntl) |
| Oct 22, 2020 | 15 | Answer to Counterclaim (9) Docket Text: ANSWER to [14] Answer to Amended Complaint, Counterclaim Plaintiffs' Reply to Defendant's Counterclaims by AbbVie Inc..(Taylor, James) |
| Oct 1, 2020 | 14 | Answer to Amended Complaint (30) Docket Text: ANSWER to Amended Complaint, re: [13] Amended Complaint, , COUNTERCLAIM against AbbVie Inc., Genentech, Inc. by Alembic Global Holding SA, Alembic Pharmaceuticals, Inc., Alembic Pharmaceuticals Ltd..(Gaza, Anne) |
| Sep 17, 2020 | 13 | ANDA Form (2) |
| Sep 17, 2020 | 13 | Patent/Trademark Report (1) |
| Sep 17, 2020 | 13 | Exhibit B (39) |
| Sep 17, 2020 | 13 | Exhibit A (38) |
| Sep 17, 2020 | 13 | Amended Complaint Redline (17) |
| Sep 17, 2020 | 13 | Main Document (17) Docket Text: First AMENDED COMPLAINT against Alembic Global Holding SA, Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc.- filed by Genentech, Inc., AbbVie Inc.. (Attachments: # (1) Amended Complaint Redline, # (2) Exhibit A, # (3) Exhibit B, # (4) Patent/Trademark Report, # (5) ANDA Form)(Taylor, James) (Attachment 1 replaced on 9/17/2020) (ntl). |
| Sep 17, 2020 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: Corrected Attachment A (redline version) added to D.I. 13 per request of counsel. (ntl) |
| Sep 2, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [12] MOTION for Pro Hac Vice Appearance of Attorney Dennies Varughese, Pharm.D. and Robert W. Stout, Esquire filed by Alembic Global Holding SA, Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc. Signed by Judge Leonard P. Stark on 9/2/20. (ntl) |
| Sep 1, 2020 | 12 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Dennies Varughese, Pharm.D. and Robert W. Stout, Esquire - filed by Alembic Global Holding SA, Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc.. (Wilson, Samantha) |
| Sep 1, 2020 | 11 | Disclosure Statement (4) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Alembic Pharmaceuticals Ltd. for Alembic Global Holding SA; Corporate Parent Alembic Global Holdings SA for Alembic Pharmaceuticals, Inc. filed by Alembic Global Holding SA, Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc.. (Gaza, Anne) |
| Sep 1, 2020 | 10 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, Defenses, COUNTERCLAIM against AbbVie Inc., Genentech, Inc. by Alembic Global Holding SA, Alembic Pharmaceuticals, Inc., Alembic Pharmaceuticals Ltd..(Gaza, Anne) |
| Aug 28, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Ashley N. Mays-Williams for AbbVie Inc. and Genentech, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-01009-LPS, 1:20-cv-00968-LPS(kmd) |
| Aug 27, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Chad J. Peterman, Eric W. Dittmann, Bruce M. Wexler, Katherine A. Daniel, Krystina L. Ho for AbbVie Inc. and Genentech, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Aug 12, 2020 | 9 | Exhibit A & B (10) |
| Aug 12, 2020 | 9 | Main Document (2) Docket Text: AFFIDAVIT of Service for Complaint served on M. Macroy on August 12, 2020, filed by AbbVie Inc., Genentech, Inc.. (Attachments: # (1) Exhibit A & B)(Taylor, James) |
| Aug 5, 2020 | 8 | Attorney Certifications (6) |
| Aug 5, 2020 | 8 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Chad J. Peterman, Eric W. Dittmann, Bruce M. Wexler, Ashley N. Mays-Williams, Katherine A. Daniel and Krystina L. Ho - filed by AbbVie Inc., Genentech, Inc.. (Attachments: # (1) Attorney Certifications)(Taylor, James) |
| Aug 5, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [8] MOTION for Pro Hac Vice Appearance of Attorney Chad J. Peterman, Eric W. Dittmann, Bruce M. Wexler, Ashley N. Mays-Williams, Katherine A. Daniel and Krystina L. Ho filed by Genentech, Inc., AbbVie Inc. Signed by Judge Leonard P. Stark on 8/5/20. (ntl) |
| Aug 5, 2020 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (nms) |
| Jul 31, 2020 | 7 | Letter (1) Docket Text: Letter to John A. Cerino from James D. Taylor, Jr. regarding Relationship of Cases. (Taylor, James) |
| Jul 31, 2020 | N/A | Remark (0) Docket Text: Remark: added related case 20-cv-968-LPS to the docket per DI #7 (rjb) |
| Jul 29, 2020 | 6 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Roche Holdings, Inc. for Genentech, Inc. filed by Genentech, Inc.. (Taylor, James) |
| Jul 29, 2020 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by AbbVie Inc.. (Taylor, James) |
| Jul 28, 2020 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,722,657. (nmg) |
| Jul 28, 2020 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 6/16/2020. Date of Expiration of Patent: 1/29/2032. Thirty Month Stay Deadline: 12/8/2022 (statutory) 10/11/2023 (extended). (nmg) |
| Jul 28, 2020 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
| Jul 28, 2020 | 1 | Civil Cover Sheet (2) |
| Jul 28, 2020 | 1 | Complaint* (1) |
| Jul 28, 2020 | 1 | Exhibit A (38) |
| Jul 28, 2020 | 1 | Main Document (14) Docket Text: COMPLAINT for PATENT INFRINGEMENT filed against Alembic Global Holding SA, Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3091257.) - filed by AbbVie Inc., Genentech, Inc. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(nmg) |
| Jul 28, 2020 | N/A | No Summons Issued (0) Docket Text: No Summons Issued. (nmg) |
